RecruitingGVHD,Acute
CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease
Eligible age
18–80 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The prediction of severe acute GVHD before it occurs is of high importance for ensuing clinical decisions and overall success of allogeneic SCT. The key immunologic signatures associated with clinical outcomes after different graft versus host disease prophylaxis methods or peripheral blood stem cell transplant are largely unknown.
Sponsor: Henry Ford Health System
You may qualify if…
- ✓ Patients \>18 year old admitted for allo SCT PB for malignant disease.
Where it's recruiting
Michigan
Detroit
Source: ClinicalTrials.gov · NCT05718791 · last updated 2026-05-01